Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours

Immunology and Cell Biology

Volumn 83, Issue 4, 2005, Pages 429-439

  Kobata, Akira ^a   Amano, Junko ^a  

^a NOGUCHI INSTITUTE   (Japan)

Author keywords

glutamyltranspeptidase; Carcinoembryonic antigen; Glycoproteins; Human chorionic gonadotropin; N linked sugar chain; Trophoblastic diseases

Indexed keywords

BETA N ACETYLGLUCOSAMINYLTRANSFERASE III; BETA N ACETYLGLUCOSAMINYLTRANSFERASE IV; BETA N ACETYLGLUCOSAMINYLTRANSFERASE V; CHORIONIC GONADOTROPIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA GLUTAMYLTRANSFERASE; GLUCOSYLTRANSFERASE; GLYCOPROTEIN; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CHO CELL; CHORIOCARCINOMA; GENETIC TRANSFECTION; LIVER CELL CARCINOMA; METASTASIS; NONHUMAN; PREGNANCY TEST; PROTEIN GLYCOSYLATION; TROPHOBLASTIC DISEASE;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARBOHYDRATE SEQUENCE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNOTHERAPY; MOLECULAR SEQUENCE DATA; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASMS;

MAMMALIA;

EID: 22944456543     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01351.x     Document Type: Article

References (72)

1. Meezan E, Wu HC, Black PH, Robbins PW. Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by Sephadex chromatography. Biochemistry 1969; 8: 2518-24.
2. Buck CA, Glick MC, Warren L. Comparative study of glycoproteins from the surface of control and Rous sarcoma virus transformed hamster cells. Biochemistry 1970; 9: 4567-76.
3. Warren L, Critchley D, Macpherson I. Surface glycoproteins and glycolipids of chicken embryo cells transformed by a temperature-sensitive mutant of Rous sarcoma virus. Nature 1972; 235: 275-8.
4. Ogata S, Muramatsu T, Kobata A. New structural characteristics of the large glycopeptides from transformed cells. Nature 1976; 259:580-2.
5. Yamashita K, Ohkura T, Tachibana Y, Takasaki S, Kobata A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J. Biol. Chem. 1984; 259: 10834-40.
6. Yamashita K, Tachibana Y, Ohkura T, Kobata A. Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J. Biol. Chem. 1985; 260: 3963-9.
7. Ujita M, Misra AKMC, Auliffe J, Hindsgaul O, Fukuda M. Poly-N-acetyllactosamine extension in N-glycans and core 2- and core 4-branched O-glycans is differently controlled by I-extension enzyme and different members of the β1,4-galactosyltransferase gene family. J. Biol. Chem. 2000; 275: 15868-75.
8. Pierce M, Arango J. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetra-antennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J. Biol. Chem. 1986; 261: 10772-7.
9. Van den Eijnden DH, Koenderman AHL, Schiphorst WECM. Biosynthesis of blood group I-active polylactosaminoglycans. J. Biol. Chem. 1988; 263: 12461-5.
10. Ujita M, McAuliffe J, Hindsgaul O, Sasaki K, Fukuda MN, Fukuda M. Poly-N-acetyllactosamine synthesis in branched N-glycans is controlled by complemental branch specificity of I-extension enzyme and beta1, 4-galactosyltransferase I. J. Biol. Chem. 1999; 274: 16717-26.
11. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 1991; 49: 945-50.
12. Asada M, Furukawa K, Segawa K, Endo T, Kobata A. Increased expression of highly branched N-glycans at cell surface is correlated with the malignant phenotypes of mouse tumor cells. Cancer Res. 1997; 57: 1073-80.
13. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. β1-6 branching of Asn-linked oligosaccharides directly associated with metastasis. Science 1987; 236: 582-5.
14. Humphries MJ, Matsumoto K, White SL, Olden K. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc. Natl. Acad. Sci. USA 1986; 83: 1752-6.
15. Guo H-B, Lee I, Kamar M, Akiyama SK, Pierce M. Aberrant N-glycosylation of betal integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res. 2002; 62: 6837-45.
16. Zheng M, Fang H, Hakomori S. Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. J. Biol. Chem. 1994; 269: 12325-31.
17. Buckhaults P, Chen L, Fregien N, Pierce M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J. Biol. Chem. 1997; 272: 19575-81.
18. Chen L, Zhang W, Fregien N, Pierce M. The Her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 1998; 17: 2087-93.
19. Guo HB, Zhang QS, Chen HL. Effects of H-ras and v-sis over expression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells. J. Cancer Res. Clin. Oncol. 2000; 126: 263-70.
20. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 1995; 130: 383-92.
21. Guo HB, Liu F, Chen HL. Increased susceptibility to apoptosis of human hepatocarcinoma cells transfected with antisense N-acetylglucosaminyltransferase V cDNA. Biochem. Biophys. Res. Commun. 1999; 264: 509-17.
22. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 2000; 6: 306-12.
23. Fukuda M, Spooncer E, Oates JE, Dell A, Klock JC. Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes. J. Biol. Chem. 1984; 259: 10925-35.
24. Saito T, Miyoshi E, Sasai K et al. A secreted type of β1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation. J. Biol. Chem. 2002; 277:17002-8.
25. Seelentag WKF, Li W-P, Schmitz S-FH et al. Prognostic value of β1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res. 1998; 58: 5559-64.
26. Stanley P, Schachter H, Ikeda Y et al. N-Acetylglucosaminyltransferases. In: Taniguchi N, Honke K, Fukuda M (eds). Handbook of Glycosyltransferases and Related Genes. Tokyo: Springer-Verlag, 2002: 59-106.
27. Endo Y, Yamashita K, Tachibana Y, Tojo S, Kobata A. Structures of the asparagines-linked sugar chains of human chorionic gonadotropin. J. Biochem. (Tokyo) 1979; 85: 669-79.
28. Mizuochi T, Nishimura R, Derappe C et al. Structures of the asparagines-linked sugar chains of human chorionic gonadotropin produced in choriocarcinoma: Appearance of triantennary sugar chains and unique biantennary sugar chains. J. Biol. Chem. 1983; 258: 14126-9.
29. Mizuochi T, Nishimura R, Taniguchi T, Utsunomiya T, Mochizuki M, Kobata A. Comparison of carbohydrate structure between human chorionic gonadotropin present in urine of patients with trophoblastic diseases and healthy individuals. Jpn. J. Cancer Res. 1985; 76: 752-9.
30. Endo T, Nishimura R, Kawano T, Mochizuki M, Kobata A. Structural differences found in the asparagines-linked sugar chains of human chorionic gonadotropins purified from the urine of patients with invasive mole and with choriocarcinoma. Cancer Res. 1987; 47: 5242-5.
31. Minowa MT, Oguri S, Yoshida A et al. cDNA cloning and expression of bovine UDP-N-acetylglucosamine: alpha1,3-D-mannoside beta1,4-N- acetylglucosaminyltransferase IV. J. Biol. Chem. 1998; 273: 11556-62.
32. Takamatsu S, Oguri S, Yoshida A et al. Unusually high expression of N-acetylglucosaminyltransferase IVa in human choriocarcinoma cell lines: A possible enzymatic basis of the formation of abnormal biantennary sugar chain. Cancer Res. 1999; 59: 3949-53.
33. Endo T, Iino K, Nozawa S, Iizuka R, Kobata A. Immobilized Datura stramonium agglutinin column chromatography, a novel method to discriminate the urinary hCGs of patients with invasive mole and choriocarcinoma from those of normal pregnant women and patients with hydatidiform mole. Jpn. J. Cancer Res. 1988; 79: 160-4.
34. Yamashita K, Hitoi A, Taniguchi N, Yokosawa N, Tsukada Y, Kobata A. Comparative study of the sugar chains of γ-glutamyltranspeptidases purified from rat liver and rat AH-66 hepatoma cells. Cancer Res. 1983; 43: 5059-63.
35. Yamashita K, Totani K, Iwaki Y et al. Comparative study of the sugar chains of γ-glutamyltranspeptidases purified from human hepatocellular carcinoma and from human liver. J. Biochem. (Tokyo) 1989; 105: 728-35.
36. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinoma by immunological tolerance and absorption techniques. J. Exp. Med. 1965; 121: 439-62.
37. Goldenberg DM, Neville AM, Carter AC et al. Carcinoembryonic antigen: Its role as a marker in the management of cancer. Cancer Res. 1981; 41: 2017-18.
38. Burtin P, Chavanel G, Hirsch-Marie H. Characterization of a second normal antigen that cross-reacts with CEA. J. Immunol. 1973; 111: 1926-8.
39. Kuroki M, Koga Y, Matsuoka Y. Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces. Cancer Res. 1981; 41: 713-20.
40. Oikawa S, Nakazato H, Kosaki G. Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem. Biophys. Res. Commun. 1987; 142: 511-18.
41. Barnett T, Zimmermann W. Workshop report. Proposed nomenclature for the carcinoembryonic antigen (CEA) gene family. Tumor Biol. 1990; 11: 59-63.
42. Yamashita K, Totani K, Kuroki M, Matsuoka Y, Ueda I, Kobata A. Structural studies of the carbohydrate moieties of carcinoembryonic antigens. Cancer Res. 1987; 47: 3451-9.
43. Yamashita K, Totani K, Iwaki Y et al. Carbohydrate structures of nonspecific cross-reacting antigen-2, a glycoprotein purified from meconium as an antigen cross-reacting with anticarcinoembryonic antigen antibody: Occurrence of complex-type sugar chains with the Galβ1-3GlcNAcβ1-3Galβ1- 4GlcNAcβ1- outer chains. J. Biol. Chem. 1989; 264: 17873-11.
44. Fukushima K, Ohkura T, Kanai M et al. Carbohydrate structures of a normal counterpart of the carcinoembryonic antigen produced by colon epithelial cells of normal adults. Glycobiology 1995; 5: 105-15.
45. Seko A, Ohkura T, Kitamura H, Yonezawa S, Sato E, Yamashita K. Quantitative differences in GlcNAc: beta1→3 and GlcNAc: beta1→4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa. Cancer Res. 1996; 56: 3468-73.
46. Koprowski H, Herlyn M, Steplewski Z. Specific antigen in serum of patients with colon carcinoma. Science 1981; 212: 53-5.
47. Magnani J, Steplewski Z, Koprowski H, Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 1983; 43: 5489-92.
48. Isshiki S, Togayachi A, Kudo T et al. Cloning, expression, and characterization of a novel UDP-galactose: beta-N-acetylglucosamine beta1,3-galactosyltransferase (beta3Gal-T5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom. J. Biol. Chem. 1999; 274: 12499-507.
49. Salvini R, Bardoni A, Valli M, Trinchera M. Beta 1,3- Galactosyltransferase beta 3Gal-T5 acts on the GlcNAc beta 1→3Gal beta 1→4GlcNAc beta 1→R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas. J. Biol. Chem. 2001; 276: 3564-73.
50. Baeckstroem D, Zhang K, Asker N, Rueelschi U, Ek M, Iiausson GC. Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line. J. Biol. Chem. 1995; 270: 13688-92.
51. Holmes EH, Hakomori S, Ostrander GK. Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1-3N- acetylglucosaminyltransferase. J. Biol. Chem. 1987; 262: 15649-58.
52. Kansas GS. Selectins and their ligands. Current concepts and controversies. Blood 1996; 88: 3259-87.
53. Lasky LA, Singer MS, Yednock TA et al. Cloning of a lymphocyte homing receptor reveals a lectin domain. Cell 1989; 56: 1045-55.
54. Johnston GI, Cook RG, McEver RP. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and lectins. Cell 1989; 56: 1033-44.
55. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1. An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-5.
56. Phillips ML, Nudelman E, Gaeta FC et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Le x. Science 1990; 250: 1130-2.
57. Berg EL, Robinson MK, Mansson O, Butcher EC, Magnani JL. A carbohydrate domain common to both sialyl Le(a) and sialyl Le(X) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J. Biol. Chem. 1991; 266: 14 869-72.
58. Takada A, Ohmori K, Takahashi N et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem. Biophys. Res. Commun. 1991; 179:713-19.
59. Mitsuoka C, Sawada-Kasugai M, Ando-Furui K et al. Identification of a major carbohydrate capping group of the 1-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis x. J. Biol. Chem. 1998; 273: 11 225-33.
60. x. Arch. Biochem. Biophys. 2004; 426: 122-31.
61. Sawada R, Tsuboi S, Fukuda M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J. Biol. Chem. 1994; 269: 1425-31.
62. a antigen. J. Biol. Chem. 1985; 260: 9388-92.
63. x determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J. Biol. Chem. 1986; 261: 3737-43.
64. Grabenhorst E, Nimtz M, Costa J, Conradt HS. In vivo specificity of human alpha 1,3/4-fucosyltransferases III-VII in the biosynthesis of Lewis X and Sialyl Lewis X motifs on complex-type N-glycans. Coexpression studies from bhk-21 cells together with human beta-trace protein. J. Biol. Chem. 1998; 273: 30985-94.
65. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression: The Warburg effect revisited. Glycocon. J. 2004; 20: 353-64.
66. Izawa M, Kumamoto K, Mitsuoka C et al. Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res. 2000; 60: 1410-16.
67. x in colon cancers. In: Abstracts of the 24th Annual Meeting of the Japan Society for Molecular Tumor Marker Research, 28 September 2004, 2004: 56-7.
68. a expression on human colon cancers. Cancer Res. 2004; 64: 4498-505.
69. a (CA 19-9) expression in digestive cancers by epigenetically suppressed transcription of 2-6 sialyltransferase gene. In: Abstracts of the 24th Annual Meeting of the Japan Society for Molecular Tumor Marker Research, 28 September 2004, 2004: 50-1.
70. Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T. Cimetidine increases survival of colorectal cancer patients with high level of sialyl Lewis-X and sialyl Lewis- A epitope expression on tumor cells. Br. J. Cancer 2002; 86: 161-7.
71. Hakomori S. Aberrant glycosylation in cancer membrane as focused on glycolipids: Overview and perspectives. Cancer Res. 1985; 42: 2405-14.
72. Kobata A, Ginsburg V. UDP-N-acetyl-D-galactosaminyltransferase, a product of gene that determines blood type A in man. J. Biol. Chem. 1970; 245: 1484-90.